Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

3.370

+0.010 (0.30%)

At close: Mar 11, 2026, 4:00 PM EDT

3.360

-0.010 (-0.30%)

After-hours: Mar 11, 2026, 5:48 PM EDT

Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	46.83	35.63	66.89	130.1	122.16	43.78
Short-Term Investments	79.78	135.93	176.64	47.5	72.08	-
Cash & Short-Term Investments	126.61	171.56	243.52	177.61	194.24	43.78
Cash Growth	-36.80%	-29.55%	37.11%	-8.56%	343.70%	568.15%
Other Receivables	-	-	-	-	-	0.11
Total Trade Receivables	-	-	-	-	-	0.11
Other Current Assets	5.54	6.75	3.09	2.72	4.42	0.54
Total Current Assets	132.15	178.31	246.62	180.33	198.66	44.43
Net Property, Plant & Equipment	-	-	-	0.27	0.04	-
Long-Term Investments	9.44	59.97	62.55	15.84	31.62	-
Other Long-Term Assets	0.63	0.72	0.96	0.15	0.01	-
Total Assets	142.22	238.99	310.13	196.59	230.33	44.43
Accounts Payable	0.68	5.65	1.38	1.64	1.09	0.53
Accrued Expenses	17.68	21.96	10.84	6.07	4.06	0.42
Short-Term Debt	3.6	-	-	-	-	-
Current Portion of Leases	-	-	0.76	0.11	-	-
Other Current Liabilities	-	-	-	-	-	5.41
Total Current Liabilities	21.96	27.61	12.97	7.81	5.15	6.37
Long-Term Debt	27.05	29.42	29.9	-	-	-
Other Long-Term Liabilities	0.04	0.15	0.28	-	-	-
Total Long-Term Liabilities	27.09	29.57	30.18	-	-	-
Total Liabilities	49.05	57.18	43.15	7.81	5.15	6.37
Common Stock	0.01	0.01	0.01	0	0	-
Additional Paid-in Capital	514.38	506.99	489.45	359.95	352.98	8.37
Accumulated Other Comprehensive Income	0.11	-0.05	0.31	-0.75	-0.23	-
Retained Earnings	-421.32	-325.13	-222.8	-170.43	-127.57	-26.97
Total Common Shareholders' Equity	93.17	181.82	266.97	188.78	225.18	-18.59
Minority Interest	-	-	-	-	-	56.65
Shareholders' Equity	93.17	181.82	266.97	188.78	225.18	38.06
Total Liabilities & Equity	142.22	238.99	310.13	196.59	230.33	44.43
Total Debt	30.65	29.42	30.65	0.11	0	0
Net Cash (Debt)	95.96	142.14	212.87	177.5	194.24	43.78
Net Cash Growth	-32.49%	-33.23%	19.93%	-8.62%	343.70%	568.15%
Net Cash Per Share	1.59	2.37	4.38	4.37	9.68	104.45
Book Value	93.17	181.82	266.97	188.78	225.18	-18.59
Book Value Per Share	1.54	3.03	5.49	4.65	11.23	-44.36
Tangible Book Value	93.17	181.82	266.97	188.78	225.18	-18.59
Tangible Book Value Per Share	1.54	3.03	5.49	4.65	11.23	-44.36

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q